The Asia Pacific Defibrillators Market is expected to grow at a CAGR of 9.2% CAGR during 2016 - 2022. The China market dominated the Asia Pacific Defibrillators Market in 2015 and would continue till 2022, growing at a CAGR of 9.7 % during the forecast period.
The India market would witness the high growth rate of 11.2 % during 2016-2022. The Implantable Cardioverter Defibrillators (ICD) market dominated the Asia Pacific Defibrillators Market in 2015 and would grow at a CAGR of 10.2% CAGR during 2016 - 2022. The Advanced Life Support (ALS) Defibrillators market is poised to attain a market value of $ 1,077.1 Million by 2022.
The Hospitals segment dominated the Asia Pacific Defibrillators market and attained a market size of $2,253.7 Million in 2015 and is expected to grow at a CAGR of 8.6 % CAGR during 2016 - 2022. The Pre-hospitals segment would attain a market size of $295.9 Million by 2022. The Public Access Markets segment would grow at a CAGR of 11.6% during the forecast period.
The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
Full Report: https://www.kbvresearch.com/asia-pacific-defibrillators-market/
The market is segmented based on product type, end use, and country.
Related Reports:
Unique Offerings 
